EN
enGene Holdings Inc. (ENGN)
NASDAQ·Healthcare·Biotechnology
$2.00
-2.93%
Mkt Cap $127.95M
Analyst Ratings
Buy
3
Hold
4
Sell
1
Price Target (14 analysts)
$3.00
Range $2.00 – $4.00
Implied Upside
+50.4%
Consensus $3.00 vs current $2.00
NASDAQ·Healthcare·Biotechnology
$2.00
-2.93%
Mkt Cap $127.95M
Buy
3
Hold
4
Sell
1
Price Target (14 analysts)
$3.00
Range $2.00 – $4.00
+50.4%
Consensus $3.00 vs current $2.00